Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway
Authors
Keywords
-
Journal
Infectious Agents and Cancer
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-20
DOI
10.1186/s13027-023-00502-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review
- (2022) Xinxin Bai et al. Vaccines
- Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression
- (2021) Shouhua Zhang et al. Infectious Agents and Cancer
- The novel antiviral properties of brassicasterol against human adenovirus
- (2021) Peifeng Yu et al. Future Virology
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- HSV-2 Infection of Human Genital Epithelial Cells Upregulates TLR9 Expression Through the SP1/JNK Signaling Pathway
- (2020) Kai Hu et al. Frontiers in Immunology
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol
- (2020) Yasuharu Yazawa et al. Journal of Natural Medicines
- Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation
- (2020) Zhuo Yu et al. CELLULAR ONCOLOGY
- Brassicasterol with Dual Anti-Infective Properties against HSV-1 and Mycobacterium tuberculosis, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments
- (2020) Sherif T. S. Hassan Biomedicines
- Brassicasterol from Edible Aquacultural Hippocampus abdominalis Exerts an Anti-Cancer Effect by Dual-Targeting AKT and AR Signaling in Prostate Cancer
- (2020) Yinzhu Xu et al. Biomedicines
- AKT as a Therapeutic Target for Cancer
- (2019) Mengqiu Song et al. CANCER RESEARCH
- Lenvatinib: A Review in Hepatocellular Carcinoma
- (2019) Zaina T. Al-Salama et al. DRUGS
- Akt in cancer: Mediator and more
- (2019) Sundaramoorthy Revathidevi et al. SEMINARS IN CANCER BIOLOGY
- Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
- (2019) Zuzana Macek Jilkova et al. Cancers
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Challenges to a Cure for HBV Infection
- (2017) Barbara Testoni et al. SEMINARS IN LIVER DISEASE
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
- (2015) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B
- (2013) Chung Hwan Jun WORLD JOURNAL OF GASTROENTEROLOGY
- Chronic hepatitis B infection in adolescents who received primary infantile vaccination
- (2012) Tzu-Wei Wu et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The plant sterol brassicasterol as additional CSF biomarker in Alzheimer’s disease
- (2011) T. Vanmierlo et al. ACTA PSYCHIATRICA SCANDINAVICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started